| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | $0.00 | $0.00 |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $104.02M | $142.47M | $170.28M | $127.44M | $83.56M |
| R&D | $77.00M | $116.37M | $141.79M | $98.40M | $60.17M |
| SG&A | $23.85M | $26.09M | $28.48M | $29.04M | $23.39M |
| Operating Income | -$104.02M | -$142.47M | -$170.28M | -$127.44M | -$83.56M |
| Interest Expense | $1.60M | $1.73M | $1.56M | $238.00K | $13.00K |
| Tax Expense | $0.00 | $0.00 | $0.00 | $64.00K | -$21.00K |
| Net Income | -$101.69M | -$134.85M | -$160.81M | -$123.48M | -$83.46M |
| EPS (basic) | -1.9000 | -2.5800 | -3.7400 | -3.0300 | -2.0700 |
| EPS (diluted) | -1.9000 | -2.5800 | -3.7400 | -3.0300 | -2.0700 |
| Shares (diluted) | $53.66M | $52.17M | $42.99M | $40.70M | $40.31M |